Bibliography
- Khoury MJ , BowenS, BradleyLA et al.: A decade of public health genomics in the United States: Centers for Disease Control and Prevention 1997–2007.Public Health Genomics12 , 20–29 (2009).
- Tolias PP , TorunerGA: The clinical utility of DNA testing.Pers. Med.7(5) , 461–464. (2010).
- Ng PC , KirknessEF: Whole genome sequencing.Methods Mol. Biol.628 , 215–226 (2010).
- Gratacòs M , CostasJ, de Cid R et al.: Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am. J. Med. Genet. B Neuropsychiatr. Genet.150B(6) , 808–816 (2009).
- Hilgert N , SmithRJ, Van Camp G: Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat. Res.681(2–3) , 189–196 (2009).
- Tucker T , MarraM, FriedmanJM: Massively parallel sequencing: the next big thing in genetic medicine.Am. J. Hum. Genet.85(2) , 142–154 (2009).
▪ Websites
- Illumina technology: VeraCode technology: enabling a broad range of multiplexing options for RNA, DNA and protein applications www.illumina.com/technology/veracode_technology.ilmn
- Illumina technical notes: Designing Custom GoldenGate® Genotyping Assays – Guidelines for efficiently creating and ordering custom GoldenGate Genotyping Assays using the Illumina Assay Design Tool www.illumina.com/documents/products/technotes/technote_goldengate_design.pdf